Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells

BACKGROUND: Flow cytometric immunophenotyping has been used to identify neoplastic plasma cell populations in patients with multiple myeloma (MM). Previous reports have described the use of several antigens, including CD38, CD138, CD56, CD117, CD52, CD19 and CD45, to distinguish distinct populations...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jeong, Tae-Dong, Park, Chan-Jeoung, Shim, Hyoeun, Jang, Seongsoo, Chi, Hyun-Sook, Yoon, Dok Hyun, Kim, Dae-Young, Lee, Jung-Hee, Lee, Je-Hwan, Suh, Cheolwon, Lee, Kyoo Hyung
Format: Artigo
Idioma:Inglês
Publicat: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2012
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3538797/
https://ncbi.nlm.nih.gov/pubmed/23320004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/kjh.2012.47.4.260
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars